This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Informa
This webinar recording is now available OnDemand.
Easing Manufacturing Bottlenecks To Meet The Potential of mRNA
Available: OnDemand
Capture key information on the expansion of mRNA technologies and drug development considerations, with discussion of:
New therapeutic areas and applications
Speed to market misconceptions
Manufacturing bottlenecks and solutions
Quality considerations for manufacturing, scale-up, and regulatory filing
Scaling needs and the benefits of CDMO partnerships
Watch now OnDemand
Andreas Kuhn
Senior Vice President RNA Biochemistry & Manufacturing, BioNTech SE
Greg Troiano
Chief Manufacturing Officer, mRNA Center of Excellence, Sanofi
Phil Challis
VP of Product Development, eTheRNA
Albert E. Price
Senior Director, CMC Development, IAVI
Don’t miss an insider’s look at navigating the challenges and opportunities for mRNA. Learn what it will take to ensure these therapies can meet their potential and improve patient prospects.
Download the recording now!
By completing this form you agree TriLink and Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest. This is subject to and TriLink’s privacy policy and Pharma Intelligence UK Ltd’s privacy policy.
